BPH: a present and future perspective on health impact

Size: px
Start display at page:

Download "BPH: a present and future perspective on health impact"

Transcription

1 BPH: a present and future perspective on health impact Burden of disease in men with moderate LUTS Dalibor Pacík This presentation is financially supported by GlaxoSmithKline. CZ/DUTT/0019/12

2 Men with moderate LUTS due to BPH may experience a substantial health burden Today Tomorrow Bother Interference with daily activities Sexual dysfunction Worry Impact on physical and mental health Impact on personal relationships Potential BPH progression raises the prospect of additional adverse impact on quality of life through worsening of symptoms, as well as AUR and the need for surgery 2

3 Pharmacotherapy of BPH does not save life but can increase its quality.

4 LUTS associated with BPH are reported to impact a patient s activities of daily living % of men reporting that urinary symptoms interfered with activities of daily living at least some of the time during the past month Garraway WM et al. Br J Gen Pract 1993;43:

5 One of the most bothersome symptoms in men with LUTS suggesting BPH is nocturia Nocturia may have a considerable adverse influence on QoL through sleep fragmentation Nocturia is cited as the most frequent cause of disturbed sleep continuity in older men Impaired sleep can have profound adverse consequences for somatic and mental health Abrams P. Eur Urol Supp 2005;3:1 7 Bonnet M H, Arand DL. Sleep Med Rev 2003;7:

6 Sleep fragmentation and deprivation associated with nocturia can have a serious impact on health in the short and the long term Short-term Long-term Increased daytime sleepiness/reduced daytime alertness Longer reaction time Reduced daytime energy Reduced psychomotor performance Reduced concentration Depression Increased susceptibility to somatic disease Increased risk of cardiovascular disease Increased risk of car accidents and/or falls with fractures Institutionalisation Death Abrams P. Eur Urol Supp 2005;3:1 7 Bonnet M H, Arand DL. Sleep Med Rev 2003;7:

7 Impact of BPH on HRQoL reflects severity of symptoms Mild symptoms Bother of urinary symptoms Interference with daily activities Worry about urologic disease Moderate-to-severe symptoms Bother of urinary symptoms Interference with daily activities Worry about urologic disease 4 6-fold worsening fold worsening 1 2-fold worsening 1 1. Girman C et al. Urology 1994;44:

8 Health-Related QoL Score (Age-Adjusted Means)* Impact of BPH on HRQoL reflects severity of symptoms Impact of bother begins with moderate symptoms LUTS Impact of interference begins with moderate symptoms Scale: 0 1 (health status: 0=best; 1=worst) *Higher scores indicate worse health status for all measures Girman C et al. Urology 1998; 51:

9 Reduction in QoL is much greater in patients with moderate-to-severe LUTS than in those with mild Men with moderate-to-severe LUTS and Enlarged Prostate were significantly more likely than those with mild symptoms to consider their prostate condition to have reduced their QoL (p<0.05) Roehrborn CG et al. Prostate Cancer Prostatic Dis 2006;9:30 4 9

10 The presence and severity of LUTS are risk factors for sexual dysfunction

11 The presence and severity of LUTS are risk factors for sexual dysfunction Sexual activity is common in a majority of men aged years and is an important component of quality of life Men with moderate-to-severe LUTS are at increased risk for Erectile dysfunction Ejaculatory dysfunction Hypoactive desire Rosen R et al. Eur Urol 2003;44: Rosen R et al. Eur Urol 2005;47:

12 Incidence (%) Erection problems are strongly associated with LUTS severity Effect of LUTS severity Effect of LUTS severity Effect of LUTS severity Age effect Rosen R et al. Eur Urol 2003; 44(6): years years years Rosen R et al. Eur Urol 2003;44:

13 Average number of sexual activities per month Reduced sexual activity is strongly associated with LUTS severity Effect of LUTS severity Effect of LUTS severity Effect of LUTS severity Age effect Rosen R et al. Eur Urol 2003; 44(6): years years years Rosen R et al. Eur Urol 2003;44:

14 Impaired sexual function is associated with reduced quality of life Rosen et al Sexual activity is common in a majority of men over age 50 and is an important component of overall quality of life. Because the inability to function sexually can erode an individual s sense of self-esteem and lead to emotional and marital tension, it is not surprising to find that QOL is diminished in men with erectile dysfunction. Althof Fugl-Meyer et al Using factor analytic technique, satisfaction with sexual life was found to be a powerful predictor for satisfaction with life as a whole. Rosen R et al. Eur Urol 2003;44: Althof SE. Urology 2002;59(6): Fugl-Meyer AR et al. Int J Impotence Res 1997;9:

15 Partners of men with LUTS due to BPH also experience significant morbidity due to their husband s condition

16 Partners of men with LUTS due to BPH also experience significant morbidity due to their husband s condition Factors mainly affecting partner s QoL Psychological burden Inadequate sex life Sleep disturbance Disruption in social life* Inability to take care of essential tasks inside and outside the house Fear of prostater cancer Fear of surgery *Significantly correlated with partner s IPSS Mitropoulos D et al. Eur Urol 2002;41:

17 The severity of LUTS can adversely impact important areas of personal relationships Men Spouses with moderate-to-severe of men with enlarged symptoms prostate were also more more likely likely than than those their with husband mild to report symptoms specific to report relationship problems concerns in their as marriage a result of their husband s condition Roehrborn CG et al. Prostate Cancer Prostatic Dis 2006;9:

18 BPH: the future perspective on health impact

19 Cumulative incidence of progression (%) 4-year cumulative incidence of clinical progression: MTOPS population year cumulative incidence of clinical progression* = 17% Disease course in placebo arm of MTOPS** highlights progressive nature of BPH Years from randomisation *Clinical progression defined as an increase above base line of 4 points in the AUA symptom score, acute urinary retention, urinary incontinence, renal insufficiency, or recurrent urinary tract infection **MTOPS = Medical Therapy of Prostatic Symptoms study McConnell JD et al. NEJM 2003;349:

20 Deterioration in symptoms is the most common manifestation of BPH progression 4.5 years mean follow up in MTOPS (Medical Therapy of Prostatic Symptoms study) McConnell JD et al. N Engl J Med 2003;349:

21 Most men with BPH worry about the potential long-term consequences of their disease Patient concerns with risk for AUR and need for surgery Emberton M et al. Int J Clin Pract 2008; 62:

22 Men with moderate/severe symptoms have greater risk of AUR - Olmsted County Study Relative risk of AUR (unadjusted) 3.2 relative risk of AUR for men with moderate/severe symptoms compared to 1.0 for those with mild symptoms > >30 Retrospective review of occurence in the subsequent 4 y Age (yrs) AUA-SI Qmax (ml/s) Prostate volume (ml) Jacobsen SJ et al. J Urol 1997;158:

23 The impact of AUR highlights the benefit of reducing the risk of the event occurring Acute urinary retention Pain Pain Short term Financial cost Recurrent hospitalization Likelihood of subsequent surgery Long term Increased risk of complications versus elective procedures Risk for recurrent retention Thomas K et al. BJU Int 2005; 95: ; Roehrborn C. Rev Urol 2005;7(suppl4):S31 S41; Choong S, Emberton M. BJU Int 2000;85:

24 Potential for occurrence of adverse events as outcomes of surgical therapies Median frequency (%) AUA Practice Guidelines Committee. J Urol 2003;170:

25 Summary Initially, the burden of disease in a man with BPH largely reflects the severity of his symptoms Men with moderate LUTS due to BPH may experience a substantial reduction in their quality of life across multiple dimensions In many men the progressive course of BPH raises the prospect of worsening symptoms, as well as AUR and the need for surgery AUR and the need for surgery are of concern to the majority of men with BPH In the short term AUR may result in pain and the need for hospitalization A significant proportion of men presenting with AUR will ultimately require surgery, and the risk of poor outcomes is increased versus elective procedures BPH-related surgery is associated with risk for adverse events 25

26 Burden of disease in men with moderate LUTS Burden of BPH TODAY TOMORROW Reflects symptom severity and HRQoL impact Reflects disease progression 26

27 What is the prevalence of BPH in men s fifth decade? 1. 20% 2. 40% 3. 60% CZ/DUTT/0019a/12

28 Case Report

29 White male 68 ys old Admitted to Internal Disease Dpt Flatness, fatigue, nausea, sickness, dyspnoea gradually progressing during last several months No serious LUTS, last weeks frequency and sometimes incontinence History uneventful, Surgery for right inguinal hernia 5 ys ago Clinical status signs of pulmonary edema Laboratory findings: kreatinin 582, urea 22,8, K 6,1, mild anemia

30 Because of elevated kreatinin and K provided dialysis Consequently urological consultation US bilateral hydronephrosis, full bladder with large prostate TRUS prostate 150 ml PSA 9,8 ng/ml F/T 44%

31 Introduced urinary catheter, residual urine 800 ml, hydronephrosis disappeared Normalization urea, kreatinin Surgery open transvesical prostatectomy 4 weeks later. Pathology report: BPH

32 BPH several acute indications for surgery, rare cases jeopardizing life This case yes (renal insufficiency, cardiac complications, sepsis ) Prevention: periodic follow up, medication when symptoms, signs of progression, prevention of progression

33 Thank you for your attention

VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS

VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS DR. FRANCIS LEE Voiding dysfunction Storage Emptying Common voiding dysfunction in elderly male Emptying BPH Storage Incontinence Overactive bladder Post-prostatectomy

More information

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP Introduction to Enlarged Prostate E. David Crawford, MD Professor of Surgery (Urology) and Radiation Oncology Head, Urologic Oncology E. David Crawford Endowed Chair in Urologic Oncology University of

More information

The Evolution of Combination Therapy. US men eligible for BPH treatment * with projected population changes

The Evolution of Combination Therapy. US men eligible for BPH treatment * with projected population changes The Management of BPH & The Impact of Combination Therapy Results Combination of Avodart and Tamsulosin (CombAT) Medical Therapy of Prostate Symptoms (MTOPS) Dr. Jack Barkin, md, fics, facs, dabu, Mcert

More information

The Hallmarks of BPH Progression and Risk Factors

The Hallmarks of BPH Progression and Risk Factors European Urology Supplements European Urology Supplements 2 (23) 2 7 The Hallmarks of BPH Progression and Risk Factors M. Emberton * Institute of Urology and Nephrology, University College London, 48 Riding

More information

The Enlarged Prostate Symptoms, Diagnosis and Treatment

The Enlarged Prostate Symptoms, Diagnosis and Treatment The Enlarged Prostate Symptoms, Diagnosis and Treatment MAC00031-01 Rev G Financial support for this seminar has been provided by NeoTract, Inc., the manufacturer of the UroLift System. 1 Today s Agenda

More information

Prostate Gland Volume and Its Relationship to Complications of Benign Prostatic Enlargement

Prostate Gland Volume and Its Relationship to Complications of Benign Prostatic Enlargement IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 6 Ver. II (Jun. 2015), PP 33-37 www.iosrjournals.org Prostate Gland Volume and Its Relationship

More information

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Diagnostic approach to LUTS in men Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Classification of LUTS Storage symptoms Voiding symptoms Post micturition

More information

Therapeutic Strategies for Managing BPH Progression

Therapeutic Strategies for Managing BPH Progression european urology supplements 5 (2006) 997 1003 available at www.sciencedirect.com journal homepage: www.europeanurology.com Therapeutic Strategies for Managing BPH Progression John M. Fitzpatrick a, *,

More information

10th anniversary of 1st validated CaPspecific

10th anniversary of 1st validated CaPspecific Quality of Life after Treatment of Localised Prostate Cancer Dr Jeremy Grummet Clinical Uro-Oncology Fellow May 28, 2008 1 Why? This is important May be viewed as soft science Until we know which treatment

More information

NOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate

NOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate NOTE: This policy is not effective until April 1, 2019. Medical Policy Manual Surgery, Policy No. 210 Transurethral Water Vapor Thermal Therapy of the Prostate Next Review: December 2019 Last Review: December

More information

Can men with prostates sized 80 ml or larger be managed conservatively?

Can men with prostates sized 80 ml or larger be managed conservatively? Original Article - Lower Urinary Tract Dysfunction Investig Clin Urol 2017;58:359-364. pissn 2466-0493 eissn 2466-054X Can men with prostates sized 80 ml or larger be managed conservatively? Alvin Lee,

More information

Benign Prostatic Hyperplasia (BPH) Important Papers / Landmark. Vijayan Manogran

Benign Prostatic Hyperplasia (BPH) Important Papers / Landmark. Vijayan Manogran Benign Prostatic Hyperplasia (BPH) Important Papers / Landmark Studies Vijayan Manogran MTOPS & CombAT PLESS SMART ALTESS ALF-ONE VA PREDICT EPICS Landmark Studies MTOPS Medical Therapy of Prostatic Symptoms

More information

BPH: Social Impact and Patient s Perspective

BPH: Social Impact and Patient s Perspective european urology supplements 5 (2006) 991 996 available at www.sciencedirect.com journal homepage: www.europeanurology.com BPH: Social Impact and Patient s Perspective Mark Emberton a, *, Guiseppe Martorana

More information

Abstract. Key words Trial without catheter, Acute urinary retention, Benign prostatic hyperplasia, Introduction

Abstract. Key words Trial without catheter, Acute urinary retention, Benign prostatic hyperplasia, Introduction The role of sustained-released alfuzosin in the treatment of acute urinary retention Mohamed Fawzi Ahmed. Department of Surgery, Ninevah College of Medicine, University of Mosul. Abstract To see whether

More information

The patient, your co-pilot in assessing LUTS

The patient, your co-pilot in assessing LUTS The patient, your co-pilot in assessing LUTS Frank Van der Aa Leuven, Belgium This symposium is supported by Astellas Pharma Europe Ltd., including speaker honoraria and production of materials the slides

More information

Shrestha A, Chalise PR, Sharma UK, Gyawali PR, Shrestha GK, Joshi BR. Department of Surgery, TU Teaching Hospital, Maharajgunj, Kathmandu, Nepal

Shrestha A, Chalise PR, Sharma UK, Gyawali PR, Shrestha GK, Joshi BR. Department of Surgery, TU Teaching Hospital, Maharajgunj, Kathmandu, Nepal Original Article Intravesical Prostatic Protrusion is better than Prostate Volume in Predicting Symptom Severity in Benign Prostatic Hyperplasia: A Prospective Clinical Study Shrestha A, Chalise PR, Sharma

More information

As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder LUTS 2. Prevalence of BPH LUTS 5

As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder LUTS 2. Prevalence of BPH LUTS 5 BPH / LUTS Dr Jonny Coxon MA MD MRCS MRCGP DRCOG Beaconsfield Medical Practice, Brighton As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder

More information

α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years Long-Term Results

α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years Long-Term Results www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.4.248 Voiding Dysfunction α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia;

More information

Chapter 4: Research and Future Directions

Chapter 4: Research and Future Directions Chapter 4: Research and Future Directions Introduction Many of the future research needs listed in the 1994 Agency for Health Care Policy and Research (AHCPR) clinical practice guideline Benign Prostatic

More information

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Benign Prostatic Hyperplasia Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied,

More information

Management of LUTS. Simon Woodhams February 2012

Management of LUTS. Simon Woodhams February 2012 Management of LUTS Simon Woodhams February 2012 The management of lower urinary tract symptoms (LUTS) in men Implementing NICE guidance May 2010 NICE clinical guideline 97 Background Lower urinary tract

More information

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014 Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia Iain McAuley September 15, 2014 Overview Review of the most recent guidelines for ED and BPH ED Guidelines CUA 2006 AUA 2011

More information

Benign Prostatic Hyperplasia (BPH):

Benign Prostatic Hyperplasia (BPH): Benign Prostatic Hyperplasia (BPH): Evidence Based Guidelines for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the pathophysiology and prevalence of BPH 2. Select the appropriate

More information

CONDUCT study A step further in changing treatment paradigm in BPH

CONDUCT study A step further in changing treatment paradigm in BPH CONDUCT study A step further in changing treatment paradigm in BPH CLUJ,25.09.2015, Adriana Stoica, Medical Advisor GSK Toate informa,ile con,nute in aceasta prezentare sunt conforme cu Rezumatul caracteris,cilor

More information

50% of men. 90% of men PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS. Want more information? What are the symptoms?

50% of men. 90% of men PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS. Want more information? What are the symptoms? PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS What is Benign Prostatic Hyperplasia (enlarged prostate)? Benign prostatic hyperplasia (BPH) is a noncancerous enlargement of the prostate, the gland that

More information

Male LUTS, OAB, Sex: natural history. JR Sathiya

Male LUTS, OAB, Sex: natural history. JR Sathiya Male LUTS, OAB, Sex: natural history JR Sathiya Definitions Newer concepts of LUTs Natural history of BPH Prevalence of LUTs Definition BPH- represents a histologic diagnosis that refers to the proliferation

More information

Treating BPH: Comparing Rezum UroLift and HoLEP

Treating BPH: Comparing Rezum UroLift and HoLEP Treating BPH: Comparing Rezum UroLift and HoLEP Scott M. Cheney MD Mayo Clinic Arizona 2018 MFMER slide-1 Welcome to AZ 2018 MFMER slide-2 Outline Background on BPH, Rezum, Urolift, HoLEP AUA Guideline

More information

Department of Urology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX

Department of Urology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX NEW PERSPECTIVES ON BPH 5- -Reductase Inhibitors Prevent the Progression of Benign Prostatic Hyperplasia Claus G. Roehrborn, MD Department of Urology, The University of Texas Southwestern Medical Center

More information

BPH / LUTS. Prevalence. Prevalence of BPH. It is abnormal NOT to have benign growth of the prostate with increasing age. Prevalence.

BPH / LUTS. Prevalence. Prevalence of BPH. It is abnormal NOT to have benign growth of the prostate with increasing age. Prevalence. BPH / LUTS Dr Jonny Coxon MA MD MRCS MRCGP DRCOG FECSM Beaconsfield Medical Practice, Brighton & Brighton & Sussex Universities NHS Trust As man draws near the common goal Can anything be sadder Than he

More information

Evaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients

Evaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/10 Evaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients N. Narayanamoorthy,

More information

The population of subjects which was statistically analyzed was the Intent-to-Treat population

The population of subjects which was statistically analyzed was the Intent-to-Treat population Study No.: ARIB3003 (Year 1) Title: A Randomized, Double-Blind, Placebo-Controlled, Two-Year Parallel-Group Study of the Efficacy and Safety of GI198745 in the Treatment and Modification of Progression

More information

Alpha antagonists from initial concept to routine clinical practice

Alpha antagonists from initial concept to routine clinical practice european urology 50 (2006) 635 642 available at www.sciencedirect.com journal homepage: www.europeanurology.com Editorial 50th Anniversary Alpha antagonists from initial concept to routine clinical practice

More information

The Journal of International Medical Research 2012; 40:

The Journal of International Medical Research 2012; 40: The Journal of International Medical Research 2012; 40: 899 908 Comparison of α-blocker Monotherapy and α-blocker Plus 5α-Reductase Inhibitor Combination Therapy Based on Prostate Volume for Treatment

More information

How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?

How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia? available at www.sciencedirect.com journal homepage: www.europeanurology.com How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?

More information

Men s Lower Urinary Tract Symptoms Are Also Mental and Physical Sufferings for Their Spouses

Men s Lower Urinary Tract Symptoms Are Also Mental and Physical Sufferings for Their Spouses J Korean Med Sci 2009; 24: 320-5 ISSN 1011-8934 DOI: 10.3346/jkms.2009.24.2.320 Copyright The Korean Academy of Medical Sciences Men s Lower Urinary Tract Symptoms Are Also Mental and Physical Sufferings

More information

Ejaculation. Emission. Ejection. Orgasm

Ejaculation. Emission. Ejection. Orgasm Ejaculation Emission Ejection Orgasm Ejaculation sc T10-L2 S2-4 Emission: vas deferens, prostate, bladder neck Post. Urethra distention Ejection: Pelvic Floor / bulbocavernous muscle contraction Orgasm:

More information

ISSN: (Print) (Online) Journal homepage:

ISSN: (Print) (Online) Journal homepage: Archives of Andrology Journal of Reproductive Systems ISSN: 0148-5016 (Print) (Online) Journal homepage: http://www.tandfonline.com/loi/iaan19 CHANGE IN INTERNATIONAL PROSTATE SYMPTOM SCORE AFTER TRANSURETHRAL

More information

A SURVEY ON LOWER URINARY TRACT SYMPTOMS (LUTS) AMONG PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH) IN HOSPITAL UNIVERSITI SAINS MALAYSIA (HUSM)

A SURVEY ON LOWER URINARY TRACT SYMPTOMS (LUTS) AMONG PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH) IN HOSPITAL UNIVERSITI SAINS MALAYSIA (HUSM) Malaysian Journal of Medical Sciences, Vol. 14, No. 2, July 2007 (67-71) SHORT COMMUNICATION A SURVEY ON LOWER URINARY TRACT SYMPTOMS (LUTS) AMONG PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH) IN HOSPITAL

More information

MMM. Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS

MMM. Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS Dr Tan & Partners MMM Vol. 1 No. 1 Morbidity & Mortality Meeting 14 th November 2014 Introduction Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS Tadalafil 5mg daily is a well established

More information

REPORTS. Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate

REPORTS. Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate Michael James Naslund, MD, MBA; Muta M. Issa, MD, MBA; Amy L. Grogg, PharmD; Michael T. Eaddy, PharmD, PhD; and Libby Black, PharmD

More information

Benign Prostatic Hyperplasia and Enlarged Prostate Guidelines: How They Can Be Useful to Primary Care

Benign Prostatic Hyperplasia and Enlarged Prostate Guidelines: How They Can Be Useful to Primary Care Volume 1, Number 1 Weill Medical College of Cornell University Reports on Men s Urologic Health 1 Editor: Steven A. Kaplan, MD, Professor of Urology, and Chief, Institute for Bladder and Prostate Health,

More information

Benign Prostatic Hyperplasia: Update on Innovative Current Treatments

Benign Prostatic Hyperplasia: Update on Innovative Current Treatments Benign Prostatic Hyperplasia: Update on Innovative Current Treatments Michael Ferrandino, MD As.soc Professor Director of Minimally Invasive Urologic Surgery Division of Urologic Surgery Duke University

More information

Managing urinary morbidity after brachytherapy. Kieran O Flynn Department of Urology, Salford Royal Foundation Trust, Manchester

Managing urinary morbidity after brachytherapy. Kieran O Flynn Department of Urology, Salford Royal Foundation Trust, Manchester Managing urinary morbidity after brachytherapy Kieran O Flynn Department of Urology, Salford Royal Foundation Trust, Manchester Themes Can we predict urinary morbidity? Prevention of urinary morbidity

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of transurethral water vapour ablation for lower urinary tract symptoms caused by

More information

Guideline for the primary care management of male lower urinary tract symptoms

Guideline for the primary care management of male lower urinary tract symptoms review Article GUIDELINES FOR LUTS M.J. SPEAKMAN et al. As my Comment in the first section of the journal suggested, the MTOPS results have offered the possibility to general practitioners of reducing

More information

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH INTRODUCTION (1) Part of male sexual reproductive organ Size

More information

Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily

Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily REVIEW Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily Claus G Roehrborn 1 Raymond C Rosen 2 1 Department of Urology, University of Texas Southwestern

More information

Case studies: LUTS. Case 1 history. Case 1 - questions. Case 1 - outcome. Case 2 - history. Case 1 learning point 14/07/2015 DR JON REES

Case studies: LUTS. Case 1 history. Case 1 - questions. Case 1 - outcome. Case 2 - history. Case 1 learning point 14/07/2015 DR JON REES Case 1 history Case studies: LUTS DR JON REES A 49 year old male comes to see you he has had gradual deterioration of his flow over the last few years- he saw a colleague of yours 6 weeks ago who recorded

More information

Male LUT/BPH. Current Issues and Unmet Needs

Male LUT/BPH. Current Issues and Unmet Needs Male LUT/BPH Current Issues and Unmet Needs What do we know, what don t we know? What do we need to know? Kevin T. McVary, MD-FACS Professor and Chair of Urology Southern Illinois University School of

More information

The Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon

The Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon Prostate case study Presented by Mr Alan Thompson Consultant Urological Surgeon 2 Part one Initial presentation A 62 year old male solicitor attends your GP surgery. He has rarely seen you over the last

More information

EAU GUIDELINES POCKET EDITION 3

EAU GUIDELINES POCKET EDITION 3 EAU GUIDELINES POCKET EDITION 3 CONTENTS: BENIGN PROSTATIC HYPERPLASIA URINARY INCONTINENCE UROLITHIASIS 2 3 EAU POCKET GUIDELINES POCKET EDITION 3 This is one of a series of convenient pocket size books

More information

Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function

Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function www.kjurology.org DOI:10.4111/kju.2011.52.1.49 Sexual Dysfunction Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile

More information

Evaluation of Recent Trends in Treatment Patterns Among Men With Benign Prostatic Hyperplasia

Evaluation of Recent Trends in Treatment Patterns Among Men With Benign Prostatic Hyperplasia 469245JMHXXX10.1177/1557988312469245A merican Journal of Men s HealthKruep et al. Article Evaluation of Recent Trends in Treatment Patterns Among Men With Benign Prostatic Hyperplasia American Journal

More information

LUTS after TURP: How come and how to manage? Matthias Oelke

LUTS after TURP: How come and how to manage? Matthias Oelke LUTS after TURP: How come and how to manage? Matthias Oelke Department of Urology Global Congress on LUTD, Rome, 26 th June 2015 Disclosures Consultant, speaker, trial participant and/or research grants

More information

Elements for a Public Summary

Elements for a Public Summary VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Benign prostatic hyperplasia (BPH), also called benign prostatic hypertrophy or benign prostatic obstruction, is a condition in

More information

Last Review Status/Date: December Summary

Last Review Status/Date: December Summary Section: Surgery Effective Date: January 15, 2016 Subject: Prostatic Urethral Lift Page: 1 of 9 Last Review Status/Date: December 2015 Summary Benign prostatic hyperplasia (BPH) is a common condition in

More information

Medical Therapy for Benign Prostatic Hyperplasia Present and Future Impact

Medical Therapy for Benign Prostatic Hyperplasia Present and Future Impact REPORTS Medical Therapy for Benign Prostatic Hyperplasia Present and Future Impact Muta M. Issa, MD, MBA; Timothy S. Regan, BPharm, RPh, CPh Abstract The purpose of this manuscript is to provide clinicians,

More information

RELATIONSHIPS BETWEEN AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX, PROSTATE VOLUME, PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

RELATIONSHIPS BETWEEN AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX, PROSTATE VOLUME, PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA American Urological Association symptom index for BPH RELATIONSHIPS BETWEEN AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX, PROSTATE VOLUME, AND DISEASE-SPECIFIC QUALITY OF LIFE QUESTION IN PATIENTS WITH

More information

Key words: Lower Urinary Tract Symptoms (LUTS), Prostatic Hyperplasia, Alpha-1 Adrenoceptor Antagonists, Tamsulosin, Terazosin.

Key words: Lower Urinary Tract Symptoms (LUTS), Prostatic Hyperplasia, Alpha-1 Adrenoceptor Antagonists, Tamsulosin, Terazosin. The Professional Medical Journal DOI: 10.17957/TPMJ/17.4102 ORIGINAL PROF-4102 PROSTATIC HYPERPLASIA; COMPARISON BETWEEN TAMSULOSIN AND TERAZOSIN FOR EFFICACY IN MEDICAL MANAGEMENT OF LOWER URINARY TRACT

More information

Consensus Meeting for Asian-Pacific BPH Guideline

Consensus Meeting for Asian-Pacific BPH Guideline Consensus Meeting for Asian-Pacific BPH Guideline Byung Ha Chung Yonsei University Health System S a t e l l i t e S y m p o s i u m I Contents Diagnosis and Treatment Guidelines for BPH Prostate Volume

More information

Low Incidence of Acute Urinary Retention in the General Male Population: TheTriumph Project

Low Incidence of Acute Urinary Retention in the General Male Population: TheTriumph Project European Urology European Urology 47 (2005) 494 498 Low Incidence of Acute Urinary Retention in the General Male Population: TheTriumph Project K.M.C. Verhamme a,b, *, J.P. Dieleman a, M.A.M. van Wijk

More information

Alpha-BlockerTherapy Can Be Withdrawn in the Majority of Men Following Initial CombinationTherapy with the Dual 5a-Reductase Inhibitor Dutasteride

Alpha-BlockerTherapy Can Be Withdrawn in the Majority of Men Following Initial CombinationTherapy with the Dual 5a-Reductase Inhibitor Dutasteride European Urology European Urology 44 (2003) 461 466 Alpha-BlockerTherapy Can Be Withdrawn in the Majority of Men Following Initial CombinationTherapy with the Dual 5a-Reductase Inhibitor Dutasteride J.

More information

Effect of Transurethral Resection of the Prostate Based on the Degree of Obstruction Seen in Urodynamic Study

Effect of Transurethral Resection of the Prostate Based on the Degree of Obstruction Seen in Urodynamic Study www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.12.840 Voiding Dysfunction/Female Urology Effect of Transurethral Resection of the Prostate Based on the Degree of Obstruction Seen in Urodynamic

More information

Serum Prostate-Specific Antigen as a Predictor of Prostate Volume in the Community: The Krimpen Study

Serum Prostate-Specific Antigen as a Predictor of Prostate Volume in the Community: The Krimpen Study european urology 51 (2007) 1645 1653 available at www.sciencedirect.com journal homepage: www.europeanurology.com Benign Prostatic Hyperplasia Serum Prostate-Specific Antigen as a Predictor of Prostate

More information

LONG-TERM SAFETY AND EFFICACY OF TAMSULOSIN FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA

LONG-TERM SAFETY AND EFFICACY OF TAMSULOSIN FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA 0022-5347/03/1702-0498/0 Vol. 170, 498 502, August 2003 THE JOURNAL OF UROLOGY Printed in U.S.A. Copyright 2003 by AMERICAN UROLOGICAL ASSOCIATION DOI: 10.1097/01.ju.0000076140.68657.fd LONG-TERM SAFETY

More information

JMSCR Vol 05 Issue 07 Page July 2017

JMSCR Vol 05 Issue 07 Page July 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i7.47 Original Research Article Tadalafil therapy

More information

Ambulatory Try off Catheter (ATOC) Program for the Patient with Acute Retention of Urine Outpatient Service

Ambulatory Try off Catheter (ATOC) Program for the Patient with Acute Retention of Urine Outpatient Service Ambulatory Try off Catheter (ATOC) Program for the Patient with Acute Retention of Urine Outpatient Service Mr. Tang, Chi Chiu Kevin (APN) Urology Center Department of Surgery Kwong Wah Hospital Redevelopment

More information

EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT

EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT Basrah Journal Of Surgery EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT MB, ChB, FIBMS, Assistant Professor

More information

Title of Research Thesis:

Title of Research Thesis: Eastern Michigan University By Fatai Osinowo Adviser s Name: Dr. Stephen Sonstein, PhD Title of Research Thesis: A sub-analyses from the Benign Prostatic Hyperplasia (BPH) Registry and Patient survey:

More information

INVESTIGATION OF LOWER URINARY TRACT SYMPTOMS IN UROLOGICAL OUTPATIENTS USING ORIGINAL IPSS PLUS POST MICTURITION DRIBBLE QUESTIONNAIRE

INVESTIGATION OF LOWER URINARY TRACT SYMPTOMS IN UROLOGICAL OUTPATIENTS USING ORIGINAL IPSS PLUS POST MICTURITION DRIBBLE QUESTIONNAIRE INVESTIGATION OF LOWER URINARY TRACT SYMPTOMS IN UROLOGICAL OUTPATIENTS USING ORIGINAL IPSS PLUS POST MICTURITION DRIBBLE QUESTIONNAIRE Tadashi Hanail*, Seiji Matsumotol*, Nobutaka Shimizu, Hirotsugu Uemural

More information

Chapter 16 URINARY, SEXUAL AND REPRODUCTIVE IMPAIRMENT

Chapter 16 URINARY, SEXUAL AND REPRODUCTIVE IMPAIRMENT Chapter 16 URINARY, SEXUAL AND REPRODUCTIVE IMPAIRMENT Introduction This chapter provides criteria for assessing permanent impairment from entitled urinary, sexual and reproductive conditions. The chapter

More information

Chapter 3: Results of the Treatment Outcomes Analyses

Chapter 3: Results of the Treatment Outcomes Analyses Chapter 3: Results of the Treatment Outcomes Analyses Introduction To determine the appropriateness of individual therapies, as well as to develop practice recommendations, the American Urological Association

More information

APPENDIX CLINICAL INPUT RESPONSES

APPENDIX CLINICAL INPUT RESPONSES CLINICAL INPUT RESPONSES AUA: American Urological Association; UCSF Med Ctr: University of California San Francisco Medical Center; PUL: prostatic urethral lift. * Indicates that information on conflicts

More information

Silodosin versus naftopidil for the treatment of benign prostatic hyperplasia: A multicenter randomized trial

Silodosin versus naftopidil for the treatment of benign prostatic hyperplasia: A multicenter randomized trial The study protocol was approved by the ethics committee and institutional review board of Nihon University School of Medicine. Written informed consent was obtained from all patients. From December 2007

More information

Single Technology Appraisal (STA) Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia

Single Technology Appraisal (STA) Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia Comment 1: the draft remit Appendix D - NICE s response to consultee and commentator comments on the draft scope and provisional matrix National Institute for Health and Clinical Excellence Single Technology

More information

Prostatic Urethral Lift

Prostatic Urethral Lift Protocol Prostatic Urethral Lift (701151) Medical Benefit Effective Date: 04/01/18 Next Review Date: 01/19 Preauthorization No Review Dates: 05/17, 01/18 Preauthorization is not required. The following

More information

Sexual Dysfunction in Aging Men With Lower Urinary Tract Symptoms

Sexual Dysfunction in Aging Men With Lower Urinary Tract Symptoms Sexual Dysfunction and Infertility Sexual Dysfunction in Aging Men With Lower Urinary Tract Symptoms Darab Mehraban, Gholam Hossein Naderi, Seyed Reza Yahyazadeh, Mahdi Amirchaghmaghi Introduction: Our

More information

The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial

The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial european urology 54 (2008) 1379 1384 available at www.sciencedirect.com journal homepage: www.europeanurology.com Benign Prostatic Hyperplasia The Relationship between Prostate Inflammation and Lower Urinary

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Policy Manual Effective Date: April 15, 2018 Related Policies: None Prostatic Urethral Lift Description Benign prostatic hyperplasia (BPH) is a common condition in older individuals that can

More information

BPH with persistently elevated PSA 아주대학교김선일

BPH with persistently elevated PSA 아주대학교김선일 BPH with persistently elevated PSA 아주대학교김선일 PSA in BPH: present status AUA & EAU BPH guideline: PSA: recommended test AUA practice guideline committee. J Urol 2003;170:530 Madersbacher. Eur Urol 2004;46:547

More information

Current drug management of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol

Current drug management of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol Drug review BPH Current drug management of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol Skyline Imaging Ltd The range of drug treatments for BPH, alone

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Policy Manual Effective Date: January 15, 2019 Related Policies: None Prostatic Urethral Lift Description Benign prostatic hyperplasia (BPH) is a common condition in older individuals that

More information

Korean Urologist s View of Practice Patterns in Diagnosis and Management of Benign Prostatic Hyperplasia: A Nationwide Survey

Korean Urologist s View of Practice Patterns in Diagnosis and Management of Benign Prostatic Hyperplasia: A Nationwide Survey Original Article DOI 10.3349/ymj.2010.51.2.248 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 51(2):248-252, 2010 Korean Urologist s View of Practice Patterns in Diagnosis and Management of Benign Prostatic

More information

Original Article - Sexual Dysfunction

Original Article - Sexual Dysfunction www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.9.608 Original Article - Sexual Dysfunction http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.9.608&domain=pdf&date_stamp=2014-09-16

More information

Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH)

Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH) The Annals of African Surgery www.sskenya.org Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH) Author: Oliech J.S. FRCS, Affiliation: Department of Surgery, University of Nairobi. P.O. Box

More information

OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1

OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1 PATIENT INFORMATION BPH affects more than 500 million men worldwide, with many men suffering from symptoms of enlarged prostate. 1 You no longer have to be one of them! OVER 70% OF MEN IN THEIR 60s HAVE

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of insertion of prostatic urethral lift implants to treat lower urinary tract symptoms

More information

Department of Urology, Cochin hospital Paris Descartes University

Department of Urology, Cochin hospital Paris Descartes University Technical advances in the treatment of localized prostate cancer Pr Michaël Peyromaure Department of Urology, Cochin hospital Paris Descartes University Introduction Curative treatments of localized prostate

More information

Hyoung Woo Kim, Dae Geun Moon, Hyun Min Kim, Jong Ho Hwang, Soon Chan Kim, Sam Geuk Nam, Jun Tag Park

Hyoung Woo Kim, Dae Geun Moon, Hyun Min Kim, Jong Ho Hwang, Soon Chan Kim, Sam Geuk Nam, Jun Tag Park www.kjurology.org http://dx.doi.org/10.4111/kju.2011.52.10.681 Voiding Dysfunction Effect of Shifting from Combination Therapy to Monotherapy of α-blockers or 5α-Reductase Inhibitors on Prostate Volume

More information

NIH Public Access Author Manuscript J Urol. Author manuscript; available in PMC 2010 May 4.

NIH Public Access Author Manuscript J Urol. Author manuscript; available in PMC 2010 May 4. NIH Public Access Author Manuscript Published in final edited form as: J Urol. 2009 December ; 182(6): 2819 2824. doi:10.1016/j.juro.2009.08.086. Intravesical Prostatic Protrusion in Men in Olmsted County,

More information

What can the primary care physician do? Brian W. Ellis

What can the primary care physician do? Brian W. Ellis What can the primary care physician do? Brian W. Ellis Consultant Urological Surgeon at Ashford & St Peter s 1983-2007 Currently Consultant Urological Surgeon at Cobham Hospital Visiting Professor at Middlesex

More information

Office Management of Benign Prostatic Enlargement

Office Management of Benign Prostatic Enlargement Focus on CME at McGill University Office Management of Benign Prostatic Enlargement Symptomatic benign prostate enlargement is a common medical problem encountered in our aging society. Watchful waiting,

More information

Wednesday 25 June Poster Session 9: BPH 1 Chairmen: M. Speakman and D. Rosario

Wednesday 25 June Poster Session 9: BPH 1 Chairmen: M. Speakman and D. Rosario Wednesday 25 June 14.30 15.30 Poster Session 9: BPH 1 Chairmen: M. Speakman and D. Rosario P080 Unreliable residual volume measurement after increased water load diuresis G. ALIVIZATOS, A. SKOLARIKOS,

More information

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms Storage Symptoms Frequency, urgency, incontinence, Nocturia Voiding Symptoms Hesitancy, poor flow, intermittency,

More information

PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment

PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA A Minimally Invasive Innovative Treatment What is the prostate? The prostate is an accessory organ of the male reproductive system.

More information

Chapter 3: Results of the Treatment Outcomes Analyses

Chapter 3: Results of the Treatment Outcomes Analyses Chapter 3: Results of the Treatment Outcomes Analyses TABLE OF CONTENTS INTRODUCTION... 3 WATCHFUL WAITING... 11 STUDY OUTCOMES... 11 MEDICAL THERAPIES... 13 ALPHA-ADRENERGIC ANTAGONISTS (ALPHA-BLOCKERS)...

More information

Recommended drug treatment of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol

Recommended drug treatment of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol Drug review BPH Recommended drug treatment of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol Skyline Imaging Ltd The development of safe and effective drugs

More information

PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA

PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA St. Louis Hospital PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA INITIAL CLINICAL RESULTS Faculty of Medical Sciences New University of Lisbon JOÃO PISCO LUÍS CAMPOS PINHEIRO TIAGO BILHIM HUGO RIO TINTO

More information

Subject: Temporary Prostatic Stent and Prostatic Urethral Lift

Subject: Temporary Prostatic Stent and Prostatic Urethral Lift 02-54000-21 Original Effective Date: 03/15/05 Reviewed: 09/27/18 Revised: 10/15/18 Subject: Temporary Prostatic Stent and Prostatic Urethral Lift THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION,

More information